相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Leukemia incidence trends at the global, regional, and national level between 1990 and 2017
Ying Dong et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia
Maria Ilaria Del Principe et al.
HAEMATOLOGICA (2016)
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia
Maria Ilaria Del Principe et al.
HAEMATOLOGICA (2016)
Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma
Lata Singh et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)
Reprogramming cell death: BCL2 family inhibition in hematological malignancies
Lydia Scarfo et al.
IMMUNOLOGY LETTERS (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Geographic distribution of hematopoietic cancers in the Nile delta of Egypt
C. M. Herzog et al.
ANNALS OF ONCOLOGY (2012)
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
Mohammad Shamsul Ola et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
Thorsten Zenz et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia
Giovanni Del Poeta et al.
LEUKEMIA & LYMPHOMA (2010)
CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival
Antonella Zucchetto et al.
CANCER RESEARCH (2009)
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies
Luca Paoluzzi et al.
BLOOD (2008)
P53 and bcl-2 assessment in serous ovarian carcinoma
J. E. Palmer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
p53 and BCL-2 as prognostic markers in endometrial carcinoma
Marcia L. M. Appel et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on Radiation Therapy Oncology Group protocol 92-02
Li Yan Khor et al.
CLINICAL CANCER RESEARCH (2007)
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia
A Zucchetto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer
H Matsumoto et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia
A Saxena et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)
S Faderl et al.
LEUKEMIA (2002)
Bcl-2 antisense oligonucleotides enhance the cytotoxicity of Chlorambucil in B-cell chronic lymphocytic leukaemia cells
C Pepper et al.
LEUKEMIA & LYMPHOMA (2001)
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
A Prokop et al.
LEUKEMIA (2000)
分享论文
